RESMED INC — Director's Dealing 2022

Aug 22, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2022-08-18

Reporting Person: Douglas Robert Andrew (President and COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-18	ResMed Common Stock	A	4328	—	Acquired	21564	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	234995	Indirect

Footnotes

F1: Represents performance-based restricted stock units granted on November 18, 2021. The shares were earned on August 18, 2022, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.

F2: Includes 61.1855 shares of ResMed stock purchased on April 29, 2022, through the ResMed Employee Stock Purchase Plan.